Cardiac toxicity in a pilot study of duvelisib and ibrutinib combination therapy for chronic lymphocytic leukaemia

Shira R. Paul, Douglas R. Rosing, Mark C. Haigney, Cody J. Peer, William D. Figg, Adrian Wiestner, Clare Sun*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)261-263
Number of pages3
JournalBritish Journal of Haematology
Volume200
Issue number2
DOIs
StatePublished - Jan 2023
Externally publishedYes

Keywords

  • B lymphocytes
  • Bruton tyrosine kinase inhibitor
  • CLL
  • cardiology
  • non-Hodgkin lymphoma

Fingerprint

Dive into the research topics of 'Cardiac toxicity in a pilot study of duvelisib and ibrutinib combination therapy for chronic lymphocytic leukaemia'. Together they form a unique fingerprint.

Cite this